Lobe Sciences Ltd. (CSE:LOBE)

Market Cap	11.10M
Revenue (ttm)	n/a
Net Income (ttm)	-5.32M
Shares Out	201.73M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	170,215
Open	0.0550
Previous Close	0.0500
Day's Range	0.0550 - 0.0550
52-Week Range	0.0100 - 0.0800
Beta	1.84
RSI	55.86
Earnings Date	Jul 24, 2025

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: LOBE

Financial Performance

In 2024, Lobe Sciences's revenue was 136,205, a decrease of -83.80% compared to the previous year's 840,534. Losses were -4.42 million, -6.09% less than in 2023.